PCME is an accredited provider specializing in innovative continuing medical education solutions.
PCME is an accredited provider specializing in innovative continuing medical education solutions.
Michael Ezekowitz, MBChB, DPhil
Vice President of Lankenau Institute of Medical Research
Vice President of Clinical Research
Main Line Hospital, Wynnewood, PA
Michael D. Ezekowitz, MBChB, DPhil graduated from the University of Cape Town Medical School in 1970. After his residency he proceeded to London University (Imperial College) on a British Council Fellowship and was awarded a DPhil degree in 1976. His fellowship in cardiology was at Johns Hopkins Hospital and his first faculty appointment was at the University of Oklahoma. In 1982, he was recruited to Yale University School of Medicine as an Associate Professor and was awarded tenure in 1990 and an honorary master's degree. In 2000, he moved to Philadelphia as the June F. Klinghoffer Professor and Chairman of Medicine at Drexel University School of Medicine. He is now the Vice President of Lankenau Institute for Medical Research (LIMR) and Vice President of Clinical Research, Main Line Hospitals. His research interests include the vascular biology of the arterial wall and thrombosis and thromboembolic disease, particularly as it relates to atrial fibrillation. He, Dr. Sam Bridges, and colleagues designed the first double blind study of warfin and proved its benefit in patients with nonvalvular atrial fibrillation, which was published in the New England Journal in 1990.
Dr. Ezekowitz's current interest in atrial fibrillation centers on the etiology of low anticoagulation rates among eligible patients with atrial fibrillation and on the study of new drugs that will prove to be more user friendly than warfin. He has presented more than 100 national and international invited lectures and been the recipient of large federal and industrial grants to support his basic and clinical research. He has published more than 300 papers and abstracts and has written a book on cardiac sources of systemic embolism. He is on the editorial boards of Circulation, American Journal of Non-Invasive Cardiology, Journal of Cardiovascular Pharmacology and Therapeutics, Heart Disease: A Journal of Cardiovascular Medicine, and American Journal of Cardiology. He reviews for the New England Journal of Medicine, and is an active non-invasive clinical cardiologist.
